NLRP3 and Sepsis: In a LPS‐induced sepsis‐associated encephalopathy model, the NU9056 treatment group exhibited an increase in Verrucomicrobia and Akkermansia, along with a significant reduction in NLRP3 inflammasome activity, alleviating the inflammatory response.138